BioProgress plc ('BioProgress' or the 'Company') (AIM: BPRG; NASDAQ: BPRG), the speciality pharma and healthcare company, today announces that it has obtained a registration for HypoSalix, an artificial saliva spray, as a medical device, through Dexo SA, the Company's French pharmaceutical division. This registration will allow BioProgress to market and partner its product in the EU and other territories worldwide, with the knowledge that the product is effective to use and has been manufactured to the required standard.
